325 Ellington Boulevard
Unit 317
Gaithersburg, MD 20878
United States
240 658 6710
https://www.bullfrogai.com
Secteur(s): Healthcare
Secteur d’activité: Health Information Services
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Vininder Singh | Founder, Chairman & CEO | 707,67k | S.O. | 1970 |
Mr. Dane R. Saglio | Chief Financial Officer | 360k | S.O. | 1958 |
Mr. J. T. Koffenberger | Chief Information Officer | S.O. | S.O. | S.O. |
Hon. Thomas W. Chittenden X, DPHIL, Ph.D. | Chief Scientific Officer | S.O. | S.O. | S.O. |
Dr. Cetin Savkli Ph.D. | Chief AI Advisor & Member of Advisory Board | S.O. | S.O. | S.O. |
Mr. William Hirschman | Chief Commercial Officer | S.O. | S.O. | S.O. |
Dr. David P. Recker FACP, FACR, M.D. | Chief Medical Officer | S.O. | S.O. | 1958 |
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
L’ISS Governance QualityScore de Bullfrog AI Holdings, Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..